ライフサイエンスコーパス: alkaline phosphatase

1 creased blood phosphorus and increased blood alkaline phosphatase).

2 pe was associated with reduced expression of alkaline phosphatase.

3 1C, cholesterol, hemoglobin, creatinine, and alkaline phosphatase.

4 ibrils and increased expression of Runx2 and alkaline phosphatase.

5 vity using a phage-based enzymatic reporter, alkaline phosphatase.

6 Ts were degraded by an intracellular enzyme, alkaline phosphatase.

7 lpha-naphthol by anti-fluorescein-conjugated alkaline phosphatase.

8 idues in the active site of Escherichia coli alkaline phosphatase.

9 kers runt-related transcription factor 2 and alkaline phosphatase.

10 o the diseases and also plasma bilirubin and alkaline phosphatase.

11 , hemoglobin, prostate-specific antigen, and alkaline phosphatase.

12 on following phosphate removal by intestinal alkaline phosphatase.

13 on (DP) of casein was performed using bovine alkaline phosphatase.

14 5, 95% CI 5.68-20.32) and a concentration of alkaline phosphatase 100 U/L or higher (2.91, 1.60-5.30)

15 r mean +/- SE markers of bone turnover (bone alkaline phosphatase: 15.8 +/- 0.59 compared with 14.0 +

16 Bezafibrate also reduced serum alkaline phosphatase (-35%, P = .03 vs placebo) correlat

17 ransferase, 21.77 U/L (18.96-24.59 U/L); for alkaline phosphatase, 88.35 U/L (58.94-117.76 U/L); and

18 colonic pathology associated with intestinal alkaline phosphatase, a mucosal defense factor that deto

19 2 expression, some dividing cells, and clear alkaline phosphatase activity (early bone marker).

20 This was confirmed by alkaline phosphatase activity and Alizarin red and Von K

21 r time, resulting in significantly increased alkaline phosphatase activity and calcium deposition of

22 Wnt10b protein levels and induced increased alkaline phosphatase activity and mineralization in oste

23 n, the number of committed osteoprogenitors, alkaline phosphatase activity and mineralization.

24 nal, based on gamma glutamyl transferase and alkaline phosphatase activity and proliferative response

25 Using alkaline phosphatase activity assays along with various

26 quantitative estimates for the intracellular alkaline phosphatase activity at five different temperat

27 reduced femur length, and 30% elevated serum alkaline phosphatase activity compared to wild type.

28 ipocytes, promoted DP markers and functional alkaline phosphatase activity from the DP cells.

29 traced SMCs in the lesion cap, and increased alkaline phosphatase activity in lesions in the Ahr knoc

30 or addition of OC protein partially rescued alkaline phosphatase activity in periodontal ligament (P

31 We also noted that alkaline phosphatase activity is rapidly restored when z

32 of osteogenic related markers (osteopontin, alkaline phosphatase activity, Alizarin red, and Von Kos

33 izarin red and van Kossa stain and increased alkaline phosphatase activity, and by increased expressi

34 Cooling disrupted sebocyte cell membranes, alkaline phosphatase activity, and significantly reduced

35 Moreover, alkaline phosphatase activity, calcium deposition and ac

36 tment can greatly promote MSC proliferation, alkaline phosphatase activity, calcium deposition and to

37 olangiocytes, including bile acids transfer, alkaline phosphatase activity, gamma-glutamyl-transpepti

38 or is based on the inhibition of immobilized alkaline phosphatase activity, in the presence of the ph

39 potential confounders, such as inflammation, alkaline phosphatase activity, low serum albumin, renal

40 ibited enhanced differentiation indicated by alkaline phosphatase activity, mineral deposition, and t

41 st differentiation as indicated by increased alkaline phosphatase activity, mineralization, and up-re

42 n factor-15 (P = 0.0001), and calcification (alkaline phosphatase activity, P < 0.01; osteocalcin, P

43 mal body weight, long bone length, and serum alkaline phosphatase activity, suggesting that tooth dys

44 inhibited osteoblast differentiation marker alkaline phosphatase activity, while miR-138 inhibitor a

45 n, and reduced type 1 collagen secretion and alkaline phosphatase activity.

46 d the majority of them stained intensely for alkaline phosphatase activity.

47 8 inhibitor and OC protein addition enhanced alkaline phosphatase activity.

48 protective effect associated with intestinal alkaline phosphatase activity.

49 of nuclear factor-kappaB ligand (RANKL), and alkaline phosphatase activity.

50 kly but had deficient mineral apposition and alkaline phosphatase activity.

51 as well as the bilirubin, transaminases, and alkaline phosphatase, after 12 months of UDCA.

52 consumption was associated with lower serum alkaline phosphatase; alanine aminotransferase; aspartat

53 g systems based on age, values of bilirubin, alkaline phosphatase, albumin, platelets, presence of ex

54 Immunohistochemistry was carried out using alkaline phosphatase (AlkP) staining of the liver.

55 All patients had serum alkaline phosphatase (ALP) > 1.67 x upper limit of norma

56 fections (HR 1.52-1.67, P = 0.007-0.03), and alkaline phosphatase (ALP) (HR 1.05, P < 0.001).

57 biliary cirrhosis (95% women) and levels of alkaline phosphatase (ALP) 1.5- to 10-fold the upper lim

58 ; this was verified by observations of lower alkaline phosphatase (ALP) activity and higher expressio

59 ibes the use of BODIPY analogs for detecting alkaline phosphatase (ALP) activity and inhibition.

60 , and 2.5% to 10% of PRP gradually increased alkaline phosphatase (ALP) activity in the cells in a do

61 new colorimetric assay for the detection of alkaline phosphatase (ALP) activity is reported based on

62 ession of osteogenic related genes, elevated alkaline phosphatase (ALP) activity, and enhanced minera

63 platform for biokits and biosensors based on alkaline phosphatase (ALP) activity/inhibition in the pr

64 iation and mineralization as demonstrated by alkaline phosphatase (ALP) activity/staining as well as

65 Alkaline phosphatase (ALP) acts as a context-dependent s

66 HOS cell bioactivity (human osteosarcoma) by alkaline phosphatase (ALP) and fluorescence microscopy w

67 ver enzymes, alanine aminotransferase (ALT), alkaline phosphatase (ALP) and gamma glutamyltransferase

68 ase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and gamma-glutamytransferase

69 correlate aBSI with the baseline covariates: alkaline phosphatase (ALP) and prostate-specific antigen

70 evations in gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP) and total bilirubin are also

71 Protein kinase (PKA) and alkaline phosphatase (ALP) are clinically relevant enzym

72 catalysis does not increase the diffusion of alkaline phosphatase (ALP) at the single-molecule level,

73 sociations of alanine transaminase (ALT) and alkaline phosphatase (ALP) at ~17.5 years with body mass

74 Alkaline phosphatase (ALP) catalyzes the hydrolisis of s

75 ochemical impedance spectroscopy (EIS) based alkaline phosphatase (ALP) detection using gold nanopart

76 e ALPL gene, encoding the tissue-nonspecific alkaline phosphatase (ALP) enzyme.

77 The self-assembly can be triggered by alkaline phosphatase (ALP) in solution or in situ by the

78 Alkaline phosphatase (ALP) is a metalloprotein found nat

79 Alkaline phosphatase (ALP) is an important biomarker, as

80 PSA levels, lower hemoglobin levels, higher alkaline phosphatase (ALP) levels and had received more

81 and 30 for evaluation of PDGF-BB levels and alkaline phosphatase (ALP) levels.

82 yroid hormone (PTH), calcium, phosphorus and alkaline phosphatase (ALP) values were measured at a ser

83 Alkaline phosphatase (ALP) was visualized in the vossicl

84 -related transcription factor 2 (Runx2), and alkaline phosphatase (ALP) were assessed in the nicotine

85 racteristics to be identified, the levels of alkaline phosphatase (ALP), a marker commonly used in cl

86 ALPL encodes tissue nonspecific alkaline phosphatase (ALP), an enzyme that promotes mine

87 ase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transamin

88 monomers upon hydrolysis of ATP catalyzed by alkaline phosphatase (ALP), and the nanofibers can be re

89 Markers of cholestasis and liver injury, alkaline phosphatase (ALP), and total and direct bilirub

90 mined by prostate-specific antigen (PSA) and alkaline phosphatase (ALP), as well as the correlation o

91 the expression of osteogenic specific genes alkaline phosphatase (ALP), Run-related transcription fa

92 ligonucleotide (DNA-lipid-P) is reported for alkaline phosphatase (ALP)-dependent cell membrane adhes

93 whereas the cortisol detection relies on an alkaline phosphatase (ALP)-labeled competitive immunoass

94 g-like phenotype, as evidenced by increasing alkaline phosphatase (ALP)-specific activity and osterix

95 e substrate 1-naphthyl phosphate (1-NP), for alkaline phosphatase (ALP).

96 endpoints for measuring disease progression: alkaline phosphatase (ALP); transient elastography (TE);

97 patic autoimmune disorders 46%; normal serum alkaline phosphatases (ALP) 74%; ALP above 1.5 times the

98 ponse to ursodeoxycholic acid therapy (i.e., alkaline phosphatase [ALP] >1.67x upper limit of normal

99 erase [AST], alanine aminotransferase [ALT], alkaline phosphatase [ALP], total bilirubin [TBIL], and

100 [AST], gamma-glutamyl transpeptidase [GGT], alkaline phosphatase [ALP], twice weekly; n = 3,216) wer

101 nt protein functions, an enzymatic reaction (alkaline phosphatase, ALP) and a ligand-protein (carboni

102 viously showed that the zebrafish intestinal alkaline phosphatase (ALPI) gene alpi.1 was induced by G

103 T63 increased the alkaline phosphatase (ALPL) activity and mineralization

104 DHT treatment increased tissue non-specific alkaline phosphatase (Alpl) mRNA expression.

105 Significant fewer transcripts of alkaline phosphatase (ALPL), osteocalcin (BGLAP), osteon

106 ion, and up-regulation of bone marker genes (alkaline phosphatase/ALPL, osteopontin/SPP1, and bone si

107 strates of both carboxylesterases (CESs) and alkaline phosphatases (ALPs).

108 tively killing cancer cells that overexpress alkaline phosphatases (ALPs).

109 Placental alkaline phosphatase also showed high expression on BeWo

110 ALPL encodes tissue-nonspecific alkaline phosphatase, an enzyme expressed in bone, teeth

111 In addition, a concerted action of alkaline phosphatase and adenylate kinase proved crucial

112 nalyzed the progression of mineralization by alkaline phosphatase and alizarin red staining.

113 Use of ursodeoxycholic acid can improve alkaline phosphatase and bilirubin concentrations but do

114 Alkaline phosphatase and bilirubin levels correlate with

115 y bioconverted into parent drug 1 in vivo by alkaline phosphatase and esterase in a stepwise manner,

116 dified with enzymes (horseradish peroxidase, alkaline phosphatase and glucose oxidase) or labelled wi

117 HRS, and the trophoblast proteins placental alkaline phosphatase and HLA-G.

118 strong antifolding activity, in complex with alkaline phosphatase and maltose-binding protein capture

119 Serum bone-specific alkaline phosphatase and osteocalcin decreased on parica

120 creases in OA and the bone-formation markers alkaline phosphatase and osteocalcin in D2J mice.

121 Elevated alkaline phosphatase and the presence of visceral metast

122 e above normal in 54 (93%) patients, whereas alkaline phosphatase and total bilirubin elevations were

123 gitis resulted in decreases from baseline in alkaline phosphatase and total bilirubin levels that dif

124 y and mineralization such as Col10, osterix, alkaline phosphatase, and bone sialoprotein.

125 keleton, Ki67, expression of osteopontin and alkaline phosphatase, and formation of mineralized nodul

126 minotransferase, aspartate aminotransferase, alkaline phosphatase, and gamma-glutamyl transferase: -

127 minotransferase, aspartate aminotransferase, alkaline phosphatase, and gamma-glutamyltransferase leve

128 d calcium at the lower limit of normal, high alkaline phosphatase, and high bone resorption biomarker

129 ic steatosis, elevated aminotransferases and alkaline phosphatase, and hypercholesterolemia, as well

130 ignificant laboratory variables (hemoglobin, alkaline phosphatase, and international normalized ratio

131 ic differentiation markers: type I collagen, alkaline phosphatase, and osteocalcin.

132 es (1, 4-beta-cellobiosidase, arylsulfatase, alkaline phosphatase, and phenol oxidase) suggesting sal

133 abnormal liver enzyme, especially increased alkaline phosphatase, and rashes involving palms and sol

134 herbicide) to inhibit butyrylcholinesterase, alkaline phosphatase, and tyrosinase, respectively.

135 variate analysis identified serum bilirubin, alkaline phosphatase, and urinary bilirubin and urobilin

136 kers relative to bone turnover markers, bone alkaline phosphatase, and urinary N-terminal cross-linke

137 USF1 activation, osteochondrogenic programs, alkaline phosphatase, and vascular smooth muscle lineage

138 ain variable fragment of antibody fused with alkaline phosphatase (anti-IC-HT2 scFv-ALP) which is abl

139 ditional knock-in reporter allele expressing alkaline phosphatase (AP) and intersectional genetics ha

140 of dissolved inorganic phosphorus (DIP), and alkaline phosphatase (AP) has been the major research fo

141 ce, increased the expression and activity of alkaline phosphatase (AP) in the cells and importantly r

142 Alkaline phosphatase (AP) infusion reduced AKI in phase

143 Alkaline phosphatase (AP) is currently being investigate

144 Several lines of evidence show that serum alkaline phosphatase (AP) is not only a signpost of chol

145 a superfamily, we turned to the well-studied alkaline phosphatase (AP) superfamily, comparing three o

146 osphate monoesterases and diesterases of the alkaline phosphatase (AP) superfamily.

147 between promiscuous members of clades of the alkaline phosphatase (AP) superfamily.

148 involved in utilizing ATP is not related to alkaline phosphatase (AP), an important DOP hydrolase, a

149 e we have studied the catalytic mechanism of alkaline phosphatase (AP), which is one of the most cata

150 accessed by microbes employing a variety of alkaline phosphatase (APase) enzymes.

151 rent concentrations of antibody labeled with alkaline phosphatase are immobilized on the pin-heads an

152 Alkaline phosphatases are ubiquitous extracellular enzym

153 unological chain and secondary antibody with alkaline phosphatase as immunological label.

154 clamp studies, treatment of the channel with alkaline phosphatase as well as analysis of dephosphomim

155 sion of bone-specific genes, osteocalcin and alkaline phosphatase as well as through the detection of

156 cantly (P < 0.05) enhanced the expression of alkaline phosphatase, as well as the rate and volume of

157 t and showed elevation of serum liver tests (alkaline phosphatase, aspartate aminotransferase, alanin

158 Serum biochemistries, including alkaline phosphatase, aspartate aminotransferase, and bi

159 educed serum alanine aminotransferase (ALT), alkaline phosphatase (AST), total bilirubin (TBIL) and d

160 Recipient serum alkaline phosphatase at 1 month and 1 year post-LDLT was

161 interleukin (IL)-1beta and IL-10, serum bone alkaline phosphatase (B-ALP) and tartrate-resistant acid

162 to bone turnover, calcium, phosphorus, bone alkaline phosphatase (b-ALP), and terminal C telopeptide

163 ta, osteoprotegerin (OPG), and bone-specific alkaline phosphatase (BALP) serum levels were determined

164 liver and kidney enzymes, and bone-specific alkaline phosphatase (BALP) serum levels were evaluated.

165 les were collected to evaluate bone-specific alkaline phosphatase (BALP), leukogram, and dosages of a

166 We observed no significant differences in alkaline phosphatase between the the simvastatin 40 mg/d

167 assessment of insulin resistance (HOMA-IR), alkaline phosphatase, body mass index, waist circumferen

168 1 diet for 2 and 4 weeks had decreased serum alkaline phosphatase but increased serum transaminases c

169 easured reaction kinetics of calf intestinal alkaline phosphatase (CIAP) immobilized in benzophenone-

170 % CI 16 months-NA) than for patients with an alkaline phosphatase concentration equal to or greater t

171 vival was longer for: patients with baseline alkaline phosphatase concentration less than the upper l

172 ase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, creatinine, and improved liver, an

173 h stripping analysis of enzymatically (using alkaline phosphatase) deposited silver.

174 te includes a putative Lon-like protease, an alkaline phosphatase domain protein, a putative RNA-bind

175 ride content and elevated ALT, bilirubin and alkaline phosphatase due to three hepatic defects: 1.6-f

176 essed with age, highly elevated bone-derived alkaline phosphatase, elevated aminotransferases, and el

177 edication and had at least one post-baseline alkaline phosphatase evaluation).

178 percentage, neutrophil-to-lymphocyte ratio, alkaline phosphatase, extent of liver involvement, prese

179 Specifically, catalase, lipase, or alkaline phosphatase-filled colloidosomes are used to tr

180 cimen, employing a well-characterized enzyme alkaline phosphatase for accurate quantification of all

181 Plasma alkaline phosphatase for both cKO models at 24 wk was re

182 strain-specific antibody functionalized with alkaline phosphatase for electrochemical detection.

183 surface components that also highly express alkaline phosphatase, for example many cancers, are susc

184 sion and activity of the zinc-requiring Pho8 alkaline phosphatase from fission yeast (Schizosaccharom

185 ed on the ability of the receptor to prevent alkaline phosphatase from hydrolysing these substrates.

186 ing Brn3a and Brn3b mutant mice in which the alkaline phosphatase gene was knocked-in (Badea et al. [

187 ing Brn3a and Brn3b mutant mice in which the alkaline phosphatase gene was knocked-in, we studied the

188 emonstrate the generality of these advances, alkaline phosphatase, glucose dehydrogenase, and laccase

189 New albumin, bilirubin, and alkaline phosphatase grade 3/4 toxicities were, respecti

190 f KIT D816V EAB >/=25%, tryptase >/=50%, and alkaline phosphatase >/=50% were significantly associate

191 severe cholestasis (bilirubin >=100 mumol or alkaline phosphatase >3-fold the upper limit of normal)

192 ostate-specific antigen, performance status, alkaline phosphatase, hemoglobin, and sites of metastase

193 e genetic labeling and whole-mount placental alkaline phosphatase histochemistry, we found that itch-

194 interval [CI], 1.02-4.06; P = 0.045), higher alkaline phosphatase (HR per 10 U/L, 1.01; 95% CI, 1.00-

195 Intestinal alkaline phosphatase (IAP) regulates bicarbonate secreti

196 tinal production and secretion of intestinal alkaline phosphatase (IAP), which induces changes in the

197 molecular aging and clearance of intestinal alkaline phosphatase (IAP).

198 ineralized differentiation, osteopontin, and alkaline phosphatase in DPSCs cultured on dentine.

199 verted to its active metabolite, WR-1065, by alkaline phosphatases in normal tissues.

200 ation in levels of total bilirubin (in 12%), alkaline phosphatase (in 21%), and aspartate aminotransf

201 s were fatigue (eight [2%] of 370 patients), alkaline phosphatase increase (five [1%]), colitis, and

202 RIgG by using a competitive assay and using alkaline phosphatase-labeled antibody.

203 boratory work-up was remarkable for elevated alkaline phosphatase level (277 U/L [4.6 mkat/L]).

204 eases than those in the placebo group in the alkaline phosphatase level (least-squares mean, -113 and

205 e dehydrogenase level (r = 0.534, P < .001), alkaline phosphatase level (r = 0.572, P < .001), circul

206 rgest diameter of the largest metastasis and alkaline phosphatase level at the time of diagnosis of m

207 An alkaline phosphatase level of > 133 mg/dL (area under th

208 nge, 10-50 U/L [0.17-0.83 mukat/L]), a serum alkaline phosphatase level of 157 U/L (2.62 mukat/L) (no

209 Laboratory tests revealed a serum alkaline phosphatase level of 370 U/L (6.1 ukat/L) (norm

210 mal range, 10-37 U/L [0.16-0.62 ukat/L]), an alkaline phosphatase level of 682 U/L (11.4 mukat/L) (no

211 mal range, 10-37 U/L [0.16-0.62 ukat/L]), an alkaline phosphatase level of 682 U/L (11.4 ukat/L) (nor

212 range, 0.4-1.9 mg/dL [6.8-32.5 umol/L]), an alkaline phosphatase level of 716 U/L (11.9 ukat/L) (nor

213 L (reference range, [158-424] x 10(9)/L), an alkaline phosphatase level of 85 U/L (1.42 mukat/L) (nor

214 The primary end point was an alkaline phosphatase level of less than 1.67 times the u

215 ed by previous docetaxel use, baseline total alkaline phosphatase level, and current bisphosphonate u

216 condition and is characterized by high serum alkaline phosphatase level, often with normal or only sl

217 us, hypertension, weight loss more than 10%, alkaline phosphatase levels 120 units/L or more, and alb

218 aminotransferase, total bilirubin, and serum alkaline phosphatase levels by 86%, 93%, and 55%, respec

219 hydroxyvitamin D were observed, whereas bone alkaline phosphatase levels decreased in the three studi

220 patients who did and did not develop ALF had alkaline phosphatase levels greater than 2 x ULN.

221 INTERPRETATION: Seladelpar normalised alkaline phosphatase levels in patients who completed 12

222 had some evidence of a beneficial effect on alkaline phosphatase levels in this largely ursodeoxycho

223 , phosphate, fibroblast growth factor-23, or alkaline phosphatase levels.

224 e lactone quorum sensing signals, as well as alkaline phosphatase, lipase and chitinase activities.

225 ting methods to separate defined mixtures of alkaline phosphatase liver/bone/kidney (ALPL)-expressing

226 ubjects with minor TT genotype at rs1256328 (alkaline phosphatase, liver/bone/kidney (ALPL)) have hig

227 gnificant difference was found for one gene, alkaline phosphatase, liver/bone/kidney (ALPL), across 3

228 PA3]; deoxyribonuclease 1-like 3 [DNASE1L3]; alkaline phosphatase, liver/bone/kidney [ALPL]; CXCR2; a

229 e was 30-40%, evidently broader than that of alkaline phosphatase measured as a model enzyme for comp

230 low from the significantly lower activity of alkaline phosphatase measured in MCF7 cells and their su

231 onally, PgPE treatment caused an increase in alkaline phosphatase mRNA expression in PDL-CD105(+) cel

232 of 102 patients), increased concentration of alkaline phosphatase (nine [4%] vs two [2%]), fatigue (s

233 tment, based on a central laboratory ULN for alkaline phosphatase of 116 U/L.

234 o-controlled, phase 2 trial of patients with alkaline phosphatase of at least 1.67 times the upper li

235 Serum alkaline phosphatase of at least 2.4 x upper limit of no

236 oci: IL6 (interleukin 6) on 7p15.3 and ALPL (alkaline phosphatase) on 1p36.12.

237 utyryl cholinesterase (BChE), tyrosinase and alkaline phosphatase or enzyme (organophosphorus hydrola

238 cellular dialysis of inorganic phosphate and alkaline phosphatase or NaN(3) treatment further support

239 ritin (OR, 1.006; CI, 1.003-1.010; P<0.001), alkaline phosphatase (OR, 1.020; CI, 1.001-1.039; P=0.03

240 e was the percentage change from baseline in alkaline phosphatase over 12 weeks, analysed in the modi

241 Blood fluoride (P < .001), alkaline phosphatase (P = .020), daily voriconazole dose

242 Changes by SUVmaxavg correlated with bone alkaline phosphatase (P = 0.0014) but not prostate-speci

243 cells increased transcript abundance of the alkaline phosphatase (phoA) gene and of the high-affinit

244 PTK2 (protein tyrosine kinase 2), and ALPP (alkaline phosphatase, placental).

245 lines in four of these measures: hemoglobin, alkaline phosphatase, platelets, and lymphocytes.

246 ber of multinucleated and tartrate-resistant alkaline phosphatase-positive cells and Calcr mRNA expre

247 GS21680 and dipyridamole treatment increased alkaline phosphatase-positive osteoblasts and diminished

248 the product of this network that is used in alkaline phosphatase production.

249 The crystal structure of tungstate-bound alkaline phosphatase provides evidence for a covalent ad

250 of hepatocellular injury markers, including alkaline phosphatase (R = 0.543, P = 0.003), aspartate a

251 ty was amplified using rabbit anti-mouse IgG-alkaline phosphatase (RalphaMIgG-ALP) functionalized wit

252 Recombinant alkaline phosphatase (recAP) deactivates LPS.

253 were measured by Griess method and secretory alkaline phosphatase reporter activity assay, respective

254 ig and anti-FITC conjugated to peroxidase or alkaline phosphatase, respectively.

255 lytic mechanisms underlying Escherichia coli alkaline phosphatase's (AP) remarkable rate enhancement

256 of nine variables: bilirubin, albumin, serum alkaline phosphatase (SAP) times the upper limit of norm

257 us containing eNOS promoter driving secreted alkaline phosphatase (SEAP) or green fluorescent protein

258 ive promoter to express a secreted embryonic alkaline phosphatase (SEAP) reporter.

259 The osteogenic markers, alkaline phosphatase, secreted phosphoprotein 1 (osteopo

260 acterized members of the PHO regulon such as alkaline phosphatases, several proteins, previously not

261 Alkaline phosphatase shifted the Fpassive-sarcomere leng

262 ed OPN and DMP1 associated with an increased alkaline phosphatase staining in the XLH cultures.

263 Periodic Acid Schiff and alkaline phosphatase staining revealed subapical accumul

264 gulating pluripotency by mRNA expression and alkaline phosphatase staining using independent short ha

265 cts (RAGE), and most cells were negative for alkaline phosphatase staining, indicating characteristic

266 signal by means of a final incubation of an Alkaline Phosphatase-streptavidin conjugate (ALP-Strp).

267 Cardiomyocytes were incubated with alkaline phosphatase, subsequently reassessed after a pe

268 c domain to be a zinc metalloprotein with an alkaline phosphatase/sulphatase fold containing three di

269 In this context, the members of the alkaline phosphatase superfamily have been extensively s

270 BcsG(DeltaN) revealed that it belongs to the alkaline phosphatase superfamily, contains a Zn(2+) ion

271 asma levels of gamma-glutamyltransferase and alkaline phosphatase than was early parenteral nutrition

272 mplification step of the enzyme, usually the alkaline phosphatase, that catalyzes the hydrolysis of a

273 the calcification protein tissue nonspecific alkaline phosphatase (TNAP) into extracellular vesicles,

274 Tissue-nonspecific alkaline phosphatase (TNAP) is a ubiquitous enzyme prese

275 Fgf23 is a suppressor of tissue nonspecific alkaline phosphatase (Tnap) transcription via FGF recept

276 Given that tissue-nonspecific alkaline phosphatase (TNAP), encoded by ALPL, is the enz

277 ons of Pi and PPi include tissue-nonspecific alkaline phosphatase (TNAP), progressive ankylosis prote

278 luding albumin, fetuin-A, apolipoprotein-A1, alkaline phosphatase, TNFR1 and CD63.

279 -5-phosphate (PA5P) is cleaved by the enzyme alkaline phosphatase to yield the basic and hydrophilic

280 oups were globally reduced using nonspecific alkaline phosphatase, Triton X-100-solubilized membranes

281 per limit of normal with total bilirubin and alkaline phosphatase two or more times the upper limit o

282 Expression of alkaline phosphatase, type 1a1 collagen, and osteocalcin

283 der N limitation and a large upregulation of alkaline phosphatase under P limitation.

284 Here, we explore TS structure in the enzyme alkaline phosphatase using hybrid Quantum Mechanics/Mole

285 D-xylosidase, and phenol oxidase) as well as alkaline phosphatase, using a per unit OM basis.

286 received seladelpar for 12 weeks had normal alkaline phosphatase values at the end of treatment, bas

287 Higher baseline alkaline phosphatase was the only significant determinat

288 Streptavidin-alkaline phosphatase was then conjugated to the MMC surf

289 ly prevalent isoforms of intestinal and bone alkaline phosphatase, we utilized syncytin-1 as a marker

290 ctural and electrostatic features of several alkaline phosphatases, we suggest that this phenomenon i

291 Mean changes from baseline in alkaline phosphatase were -2% (SD 16) in the placebo gro

292 lysis, tumor size, AFP < 100 ng/mL and serum alkaline phosphatase were independent factors for surviv

293 Levels of gamma glutamyl transferase and alkaline phosphatase were measured in cholangiocytes.

294 ring skin morphogenesis (NCAM, versican, and alkaline phosphatase) were all severely altered in Tfam(

295 her stimulation was inhibited by addition of alkaline phosphatase, which in turn, was reversed by the

296 ver, a significant increase in bone-specific alkaline phosphatase, which is a bone-formation marker,

297 Most individuals tested showed elevated alkaline phosphatase, which is a characteristic of the i

298 uals have slightly decreased levels of serum alkaline phosphatase, while eight do not.

299 monstrate that SapM is an atypical monoester alkaline phosphatase, with a serine-based mechanism of c

300 e able to trap beads labeled with the enzyme alkaline phosphatase without requiring any mechanical re